Ex-Allergan leader joins BioMarin board; Ex-FDA official Dr. Goodman joins GSK board; Dr. Reddy's relaunches generic Nexium in a new color;

> Former Allergan CEO David Pyott has joined BioMarin's board of directors. Report

> GlaxoSmithKline has named former FDA chief scientist Dr. Jesse Goodman to its board of directors. Release

> NHS has decided to return to its original recommendation that Merck's Ezetrol (Zetia) be used for treating primary hypercholesterolemia in some adults. Story

> Dr. Reddy's Laboratories has relaunched its generic version of AstraZeneca heartburn med Nexium after a U.S. court made it stop using the color purple. Story

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

The role of distributors like AmerisourceBergen, is to ensure patients can get access to therapies, no matter where they present.